查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1421807

關節疼痛注射市場、份額、規模、趨勢、行業分析報告：按產品、按關節類型、按分銷管道、按地區、按細分市場、預測，2023-2032年

Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product ; By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research最新研究顯示，到2032年，全球關節止痛注射劑市場規模預計將達到123.6億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

這是擴大關節疼痛注射適應症的絕佳機會。 目前，這些注射劑用於治療骨關節炎和相關疾病。 然而，研發工作正在探索可能涵蓋更廣泛的關節疾病的新適應症，例如肌腱炎、滑囊炎和其他肌肉骨骼疾病。

含有富血小板血漿 (PRP) 的生物關節疼痛注射劑、幹細胞療法和透明質酸衍生物的開發和使用帶來了顯著的增長機會。 生物注射具有再生潛力，可以促進組織修復和癒合。 將生物製劑引入關節疼痛注射市場帶來了先進和整體的治療選擇，特別是對於尋求關節疾病再生解決方案的患者。

個人化醫療正在各個醫療保健領域引起關注。 根據每位患者的特定關節狀況、病史和遺傳因素，為其量身訂做關節疼痛注射劑，可以大大改善治療結果。 透過客製化藥物選擇、劑量和治療計劃，醫療保健提供者可以優化關節疼痛注射的有效性，並為患者提供先進的疼痛管理解決方案。

在後新冠時代，遠距醫療和虛擬醫療就診已被廣泛採用。 患者越來越願意遠距諮詢關節疼痛問題，醫療保健提供者正在利用遠距醫療來評估、診斷關節疼痛並開出注射藥物。 這種整合提供了便利，減少了親自就診的需要，與疫情導致的患者偏好的變化一致。

患者體驗變得越來越重要。 醫療保健提供者致力於創建一個以患者為中心的環境，以培養信任和滿意度。 這種方法包括加強溝通、個人化護理計劃以及為尋求關節疼痛注射的患者提供全面支持。

關節痛注射劑市場報告亮點

由於對緩解疼痛和改善關節的非手術選擇的需求不斷增加，透明質酸注射已成為最大的細分市場。

由於膝關節相關疾病的高盛行率、對微創治療的偏好以及患者意識的提高，膝關節已成為最大的部位

主要是由於消費者需求、便利性、可訪問性以及與電子商務的融合不斷增長。

由於人口老化、骨關節炎等關節相關疾病的盛行率上升以及對非手術治療方案的需求不斷增長，北美地區在 2022 年佔據了大部分市場份額。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章全球關節止痛注射市場洞察

  • 關節止痛注射市場 - 關節類型概況
  • 麻痺注射液市場動態
    • 促進因素和機會
      • 人口老化、關節疾病流行、對微創治療的需求不斷增加
      • 生物技術與創新配方的進步
    • 抑制因素和挑戰
      • 嚴格的監管審批和合規挑戰
  • PESTEL 分析
  • 關節痛注射劑市場關節類型趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球關節疼痛注射市場，依產品

  • 主要發現
  • 簡介
  • 皮質類固醇注射液
  • 玻尿酸注射液
  • 多血小板血漿注射
  • 幹細胞注射
  • 其他

第 6 章全球關節疼痛注射劑市場（依通路）

  • 主要發現
  • 簡介
  • 零售藥局
  • 醫院藥房
  • 網路藥局

第 7 章全球關節疼痛注射市場，依關節類型劃分

  • 主要發現
  • 簡介
  • 臀部
  • 膝蓋
  • 肩膀和肘部
  • 手和手腕
  • 其他

第 8 章全球關節疼痛注射市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年關節痛注射劑市場評估（按地區）
  • 關節痛注射市場 - 北美
    • 北美：關節止痛注射市場，按產品，2019-2032 年
    • 北美：關節止痛注射市場，依關節型，2019-2032 年
    • 北美：關節止痛注射市場，依通路劃分，2019-2032 年
    • 關節痛注射劑市場 - 美國
    • 關節疼痛注射市場 - 加拿大
  • 關節痛注射市場 - 歐洲
    • 歐洲：關節止痛注射市場，依產品分類，2019-2032 年
    • 歐洲：關節止痛注射劑市場，以關節類型，2019-2032 年
    • 歐洲：關節止痛注射市場，依通路劃分，2019-2032 年
    • 關節痛注射劑市場 - 英國
    • 關節痛注射劑市場 - 法國
    • 關節疼痛注射劑市場 - 德國
    • 關節痛注射劑市場 - 義大利
    • 關節疼痛注射市場 - 西班牙
    • 關節疼痛注射劑市場 - 荷蘭
    • 關節疼痛注射市場 - 俄羅斯
  • 關節痛注射市場 - 亞太地區
    • 亞太地區：關節止痛注射市場，按產品，2019-2032 年
    • 亞太地區：關節止痛注射市場，依關節類型，2019-2032 年
    • 亞太地區：關節止痛注射市場，依通路劃分，2019-2032 年
    • 麻痺注射市場 - 中國
    • 關節痛注射劑市場 - 印度
    • 關節疼痛注射市場 - 馬來西亞
    • 麻痺注射劑市場－日本
    • 關節痛注射劑市場－印度尼西亞
    • 麻痺注射劑市場－韓國
  • 關節疼痛注射劑市場 - 中東和非洲
    • 中東和非洲：關節止痛注射市場，按產品，2019-2032 年
    • 中東和非洲：關節止痛注射市場，按關節類型，2019-2032 年
    • 中東和非洲：關節止痛注射市場，依通路劃分，2019-2032 年
    • 關節痛注射劑市場－沙烏地阿拉伯
    • 關節痛注射劑市場 - 阿拉伯聯合大公國
    • 關節痛注射劑市場 - 以色列
    • 關節疼痛注射劑市場 - 南非
  • 關節痛注射劑市場－拉丁美洲
    • 拉丁美洲：關節止痛注射市場，按產品，2019-2032 年
    • 拉丁美洲：關節止痛注射市場，依關節類型，2019-2032 年
    • 拉丁美洲：關節止痛注射市場，依通路劃分，2019-2032 年
    • 關節疼痛注射劑市場 - 墨西哥
    • 關節疼痛注射劑市場 - 巴西
    • 麻痺注射液市場－阿根廷

第 9 章競爭態勢

  • 擴張與收購分析
    • 擴大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 10 章公司簡介

  • AbbVie Inc
  • Alkem Laboratories
  • Anika Therapeutics
  • Bioventus
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • GlaxoSmithKline（GSK）
  • Johnson & Johnson
  • Merck
  • Pacira BioSciences, Inc.
  • Pfizer
  • Sanofi
  • Seikagaku Corporation
  • Teva Pharmaceuticals
  • Zimmer Biomet
Product Code: PM4129

The global joint pain injections market size is expected to reach USD 12.36 billion by 2032, according to a new study by Polaris Market Research. The report "Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Stem Cell Injections, Others); By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

There is a significant opportunity to expand the indications for joint pain injections. Currently, these injections are used for osteoarthritis and related conditions. However, research and development efforts are exploring new indications, potentially covering a broader range of joint conditions, such as tendinitis, bursitis, and other musculoskeletal disorders.

The development and use of biologic joint pain injections, including platelet-rich plasma (PRP), stem cell therapies, and hyaluronic acid derivatives, present a notable growth opportunity. Biologic injections have regenerative potential and can stimulate tissue repair and healing. Incorporating biologics into the joint pain injection market introduces advanced and holistic treatment options, particularly for patients seeking regenerative solutions for their joint conditions.

Personalized medicine is gaining prominence across various healthcare sectors. Tailoring joint pain injections to individual patients based on their specific joint condition, medical history, and genetic factors significantly enhances treatment outcomes. By customizing the choice of medication, dosage, and treatment plan, healthcare providers optimize the effectiveness of joint pain injections and deliver highly tailored pain management solutions to patients.

The adoption of telemedicine and virtual healthcare consultations has become more widespread in the post-COVID era. Patients are increasingly open to discussing joint pain issues remotely, and healthcare providers are leveraging telemedicine to evaluate, diagnose, and prescribe joint pain injections. This integration offers convenience and reduces the need for in-person visits, which aligns with pandemic-induced changes in patient preferences.

The patient experience has gained significance. Healthcare providers are focusing on creating a patient-centered environment that fosters trust and satisfaction. This approach includes enhanced communication, personalized care plans, and comprehensive support for individuals seeking joint pain injections.

Joint Pain Injections Market Report Highlights

Hyaluronic acid injections emerged as the largest segment on account of greater demand for non-surgical alternatives for pain relief and joint improvement

Knee emerged as the largest segment on account of higher incidence of knee-related conditions, preference towards less invasive treatments, and increased patient awareness

Retail pharmacies held the maximum market revenue share in 2022, mainly due to growing consumer demand, convenience, easy access, and e-commerce integration

North America region dominated the market with a majority share in 2022, owing to an aging population, rising prevalence of joint-related conditions like osteoarthritis, and growing demand for non-surgical treatment options

The global key market players include: Anika Therapeutics, Bioventus, Eli Lilly and Company, Ferring Pharmaceuticals, and Pacira BioSciences, Inc., among others

Polaris Market Research has segmented the Joint Pain Injections market report based on product, joint type, distribution channel, and region:

Joint Pain Injections, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma Injections
  • Stem Cell Injections
  • Others

Joint Pain Injections, Joint Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hip
  • Knee
  • Shoulder and Elbow
  • Hand and Wrist
  • Others

Joint Pain Injections, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Joint Pain Injections, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Joint Pain Injections Market Insights

  • 4.1. Joint Pain Injections Market - Joint Type Snapshot
  • 4.2. Joint Pain Injections Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Aging population, prevalence of joint disorders, and rise in demand for minimally invasive treatments
      • 4.2.1.2. Advancements in biotechnology and innovative formulations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory approvals and compliance challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Joint Pain Injections Market Joint Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Joint Pain Injections Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Corticosteroid Injections
    • 5.3.1. Global Joint Pain Injections Market, by Corticosteroid Injections, by Region, 2019-2032 (USD Billion)
  • 5.4. Hyaluronic Acid Injections
    • 5.4.1. Global Joint Pain Injections Market, by Hyaluronic Acid Injections, by Region, 2019-2032 (USD Billion)
  • 5.5. Platelet-Rich Plasma Injections
    • 5.5.1. Global Joint Pain Injections Market, by Platelet-Rich Plasma Injections, by Region, 2019-2032 (USD Billion)
  • 5.6. Stem Cell Injections
    • 5.6.1. Global Joint Pain Injections Market, by Stem Cell Injections, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Joint Pain Injections Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Joint Pain Injections Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global Joint Pain Injections Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Global Joint Pain Injections Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.5. Online Pharmacies
    • 6.5.1. Global Joint Pain Injections Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

7. Global Joint Pain Injections Market, by Joint Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • 7.3. Hip
    • 7.3.1. Global Joint Pain Injections Market, by Hip, By Region, 2019-2032 (USD Billion)
  • 7.4. Knee
    • 7.4.1. Global Joint Pain Injections Market, by Knee, By Region, 2019-2032 (USD Billion)
  • 7.5. Shoulder and Elbow
    • 7.5.1. Global Joint Pain Injections Market, by Shoulder and Elbow, By Region, 2019-2032 (USD Billion)
  • 7.6. Hand and Wrist
    • 7.6.1. Global Joint Pain Injections Market, by Hand and Wrist, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Joint Pain Injections Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Joint Pain Injections Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Joint Pain Injections Market - North America
    • 8.3.1. North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Joint Pain Injections Market - U.S.
      • 8.3.4.1. U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Joint Pain Injections Market - Canada
      • 8.3.5.1. Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Joint Pain Injections Market - Europe
    • 8.4.1. Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Joint Pain Injections Market - UK
      • 8.4.4.1. UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Joint Pain Injections Market - France
      • 8.4.5.1. France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Joint Pain Injections Market - Germany
      • 8.4.6.1. Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Joint Pain Injections Market - Italy
      • 8.4.7.1. Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Joint Pain Injections Market - Spain
      • 8.4.8.1. Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Joint Pain Injections Market - Netherlands
      • 8.4.9.1. Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Joint Pain Injections Market - Russia
      • 8.4.10.1. Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Joint Pain Injections Market - Asia Pacific
    • 8.5.1. Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Joint Pain Injections Market - China
      • 8.5.4.1. China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Joint Pain Injections Market - India
      • 8.5.5.1. India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Joint Pain Injections Market - Malaysia
      • 8.5.6.1. Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Joint Pain Injections Market - Japan
      • 8.5.7.1. Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Joint Pain Injections Market - Indonesia
      • 8.5.8.1. Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Joint Pain Injections Market - South Korea
      • 8.5.9.1. South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Joint Pain Injections Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Joint Pain Injections Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Joint Pain Injections Market - UAE
      • 8.6.5.1. UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Joint Pain Injections Market - Israel
      • 8.6.6.1. Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Joint Pain Injections Market - South Africa
      • 8.6.7.1. South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Joint Pain Injections Market - Latin America
    • 8.7.1. Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Joint Pain Injections Market - Mexico
      • 8.7.4.1. Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Joint Pain Injections Market - Brazil
      • 8.7.5.1. Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Joint Pain Injections Market - Argentina
      • 8.7.6.1. Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Alkem Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Anika Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bioventus
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly and Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Ferring Pharmaceuticals
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GlaxoSmithKline (GSK)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pacira BioSciences, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Seikagaku Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceuticals
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zimmer Biomet
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 3 Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 4 Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 11 Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Canada: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 14 Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Europe: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 17 UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 UK: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 20 France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 France: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Germany: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 26 Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Italy: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 29 Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Spain: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 35 Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Russia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 41 China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 44 India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 50 Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 65 UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 UAE: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 68 Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Israel: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 South Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Latin America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Mexico: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Argentina: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Joint Pain Injections Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Joint Pain Injections Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Joint Pain Injections Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Joint Type
  • Figure 11. Global Joint Pain Injections Market, by Joint Type, 2022 & 2032 (USD Billion)
  • Figure 12. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Joint Pain Injections Market